Luong, Thong The
(2022)
Role and regulation of yeast Hrq1 and its human homolog, RECQL4, during DNA crosslink repair.
Doctoral Dissertation, University of Pittsburgh.
(Unpublished)
This is the latest version of this item.
Abstract
Human RECQL4 is a member of the RecQ family of DNA helicases and functions during DNA replication and repair. RECQL4 mutations are associated with developmental defects and cancer. Although RECQL4 mutations lead to disease, RECQL4 overexpression is also observed in cancer, including breast and prostate. Thus, tight regulation of RECQL4 protein levels is crucial for genome stability. Because mammalian RECQL4 is essential, how cells regulate RECQL4 protein levels is largely unknown. Utilizing budding yeast, we investigated the RECQL4 homolog, HRQ1, during DNA crosslink repair. We find that Hrq1 functions to mediate bypass of intrastrand crosslinks. Although Hrq1 is involved in the processing of cisplatin-induced lesions, it is paradoxically degraded by the proteasome following cisplatin treatment. By identifying the targeted lysine residues, we show that preventing Hrq1 degradation results in increased recombination and mutagenesis following cisplatin exposure. Like yeast, human RECQL4 is similarly degraded upon exposure to crosslinking agents and over-expression of RECQL4 results in increased RAD51 foci and mutagenesis. Using bioinformatic approaches, we demonstrate a link between RECQL4 overexpression and good clinical response in cisplatin-treated triple negative breast cancers. Overall, our study uncovers a role for Hrq1/RECQL4 in DNA intrastrand crosslink processing and its protein regulation through proteasomal degradation.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
University of Pittsburgh ETD
|
Status: |
Unpublished |
Creators/Authors: |
|
ETD Committee: |
|
Date: |
15 June 2022 |
Date Type: |
Publication |
Defense Date: |
13 April 2022 |
Approval Date: |
15 June 2022 |
Submission Date: |
28 April 2022 |
Access Restriction: |
1 year -- Restrict access to University of Pittsburgh for a period of 1 year. |
Number of Pages: |
149 |
Institution: |
University of Pittsburgh |
Schools and Programs: |
School of Medicine > Molecular Pharmacology |
Degree: |
PhD - Doctor of Philosophy |
Thesis Type: |
Doctoral Dissertation |
Refereed: |
Yes |
Uncontrolled Keywords: |
RECQL4, Hrq1, RecQ Helicases, Intrastrand Crosslink, Proteasomal regulation, Recombination, RAD51, Mutation |
Date Deposited: |
15 Jun 2022 14:02 |
Last Modified: |
15 Jun 2022 14:02 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/42951 |
Available Versions of this Item
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
 |
View Item |